CT-FFR, Heartflow Analysis, coronary artery disease, EuroPCR, RIPCORD

Adding the HeartFlow FFRCT Analysis to a standard coronary computed tomography angiogram (cCTA) may change the course of treatment in more than one-third of patients with coronary artery disease. This conclusion was discussed in a study presented at the EuroPCR 2015 conference.
botox, atrial fibrillation, cardiac surgery, HRS

A study presented at Heart Rhythm 2015 found that botulinum toxin (botox) injections into epicardial fat pads during coronary artery bypass graft (CABG) surgery can be beneficial for the patient. The injection not only reduces the incidence of post-operative atrial fibrillation (AF), but also provides substantial AF suppression after one year.

New data from St. Jude Medical found that patients with cardiac devices who use remote monitoring have significantly fewer hospitalizations and lower overall healthcare costs than patients who do not. The data was presented during a late-breaking clinical trial session during Heart Rhythm 2015, the Heart Rhythm Society’s annual scientific sessions. The findings were a result of a five-year study, one of the largest to date on remote monitoring technologies.

Chest pain sends more than 7 million Americans to the emergency department each year. About half of them are admitted to the hospital for further observation, testing or treatment. Now, emergency medicine physicians at The Ohio State University Wexner Medical Center and Mount Carmel Health System believe that number can be significantly reduced.

A new epicardial pacing lead has been cleared by the U.S. Food and Drug Adminitysration (FDA) as an option for the implant of a pacemaker, defibrillator, or cardiac resynchronization therapy (CRT) device. The lead is indicated when other types of leads cannot be implanted. Examples include patients who have small veins, congenital heart disease, abnormalities of the tricuspid valve or when other leads are already in place, preventing additional leads in the veins.

Shimadzu Medical Systems USA announced the first U.S. West Coast installation of its Trinias C-12 high performance “crossover” system at Kalispell Regional Medical Center in Kalispell, Montana. Shimadzu dealer/partner Core Medical Imaging Inc. of Kenmore, Washington, completed the installation of the angiographic system, which went into operation at the medical center in late April.

Edwards, Fortis, transcatheter mitral valve, trial, halts enrollment

Edwards Lifesciences announced it has temporarily halted its clinical trial of the Fortis mitral transcatheter heart valve. The company said that in consultation with trial investigators, it was decided to voluntarily implement a temporary pause on enrollment in its Fortis clinical program because of evidence of valve thrombosis. The company said the issue warrants additional investigation before restarting enrollment.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now